
A new discovery has been reported by a team of researchers that will lead to the development of new way to tackle aggressive breast cancer. The breast cancer subtype in question is commonly called "HER2-positive"; it's a subset of the disease affecting about one patient in four, in which tumor cells overexpress a signaling protein called HER2. The blockbuster drug Herceptin is a treatment of choice for many women with HER2-positive breast cancer, but ...
Read More
No comments:
Post a Comment